NCT02060604View on ClinicalTrials.gov

Pilot Study of Ranibizumab With and Without Ketorolac Eyedrops for Exudative Age-related Macular Degeneration

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Wet Macular Degeneration
Interventions
DRUG

Ketorolac + Ranibizumab

3 monthly ranibizumab, then as needed Ketorolac TID

DRUG

Ranibizumab

3 monthly ranibizumab, then as needed

Trial Locations (1)

25123

Spedali Civili di Brescia, Brescia

All Listed Sponsors
lead

Università degli Studi di Brescia

OTHER

NCT02060604 - Pilot Study of Ranibizumab With and Without Ketorolac Eyedrops for Exudative Age-related Macular Degeneration | Biotech Hunter | Biotech Hunter